This article is a commentary on:
Commentary: Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid
Jiaheng Xie
Yuan Cao
Liang Chen
Ming Wang- 1Department of Burn and Plastic Surgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
- 2Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China
- 3Department of General Surgery, Fuyang Hospital Affiliated to Anhui Medical University, Fuyang, China
By Xia Y, Wang Y and Xiao Y (2022). Front. Immunol. 13:868685. doi: 10.3389/fimmu.2022.868685
Introduction
Keloid is an abnormal healing process of the wound, which is often secondary to the traumatic site, surgical incision, and even the needle path (1–3). Due to its rapid proliferation and growth rate, the keloid often protrudes from the skin and extends beyond the wound edge (4). This makes keloid a nasty disease that seriously affects their daily life and psychology (5). Histologically, the keloid is characterized by significant overformation of collagen fibers (6). It is worth mentioning that the immune microenvironment, previously thought to play an important role in tumors, is also believed to be involved in the formation and development of keloid in recent years (7). Multiple types of immune cells are speculated to constitute the chronic inflammatory background of keloid, and the inflammatory factors are involved in the activation and maintenance of keloid growth pathways (8). However, the keloid’s immune microenvironment is not well understood.
In recent years, advances in bioinformatics techniques have made it possible to explore keloid genomics, proteomics, and the immune microenvironment in depth. In our previous paper “Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid” which was published on 22 December 2021 in Frontiers in Immunology, the genomics of keloid was explored to a certain extent and tenascin-c(TNC) was identified as a robust marker of keloid by single-cell sequencing analysis and WGCNA (9). This article was commented by Xia et al. on Apr 04, 2022 (10). We are pleased to see that Xia et al. have added co-expression analysis, enrichment analysis, and correlation analysis of epithelial mesenchymal transformation(EMT)of TNC in keloid in that commentary article (10). The author’s research can provide some reference for the role of TNC in keloid. However, the gene regulation mechanism of TNC in keloid and its role in immune microenvironment remain unclear.
In this response, we further explored the regulatory mechanism of TNC in keloid and its role in the immune microenvironment. First, we constructed the TNC’s competitive endogenous RNA (ceRNA) regulatory network in keloid by Mirtarbase and Starbase (Figure 1A). In this ceRNA network, we can see the interaction between TNC and transcription factors and non-coding RNAs. Subsequent immune correlation analysis showed that TNC had a significant negative correlation with CD4+ T cells, memory B cells and Type 2 T helper cells in keloid (Figure 1B). However, TNC showed significant positive correlation with neutrophils and monocytes in keloid (Figure 1B). This provides some reference for us to understand the role of TNC in the inflammatory background of keloid.
FIGURE 1
Figure 1 (A) The competitive endogenous RNA (ceRNA) regulatory network of TNC in keloid. (B) Immune correlation analysis of TNC in keloid. TNC had a significant negative correlation with CD4+ T cells, memory B cells and Type 2 T helper cells in keloid. And TNC showed significant positive correlation with neutrophils and monocytes in keloid.
Tenascin-c (TNC), as an extracellular matrix protein, plays an important role in the maintenance of normal physiological functions and various pathological processes. In recent years, TNC has been widely studied for its important role in wound healing and the pathogenesis of keloid. In 1999, Dalkowski et al. found that TNC was highly expressed in keloid compared with normal tissues (11). That same year, Yamada found that Tocoretinate inhibited the contraction of collagen matrix in human fibroblasts with high TNC expression (12). Our previous study identified TNC as the hub gene in the pathogenesis of keloid through single-cell sequencing analysis and weighted coexpression analysis. These evidences all suggest that TNC may be a potential target for keloid therapy in the future. More studies are needed in the future to explore the significance of TNC in keloid.
Author Contributions
JX and LC designed the study. LC was involved in database search and statistical analyses. LC and JX were involved in the writing of manuscript and its critical revision. MW and JX was responsible for the submission of the final version of the paper. All authors approved the final version. All authors agree to be accountable for all aspects of the work.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We are very grateful for data provided by databases.
References
1. Hawash AA, Ingrasci G, Nouri K, Yosipovitch G. Pruritus in Keloid Scars: Mechanisms and Treatments. Acta Derm Venereol (2021) 101(10):adv00582. doi: 10.2340/00015555-3923
2. Ud-Din S, Bayat A. Keloid Scarring or Disease: Unresolved Quasi-Neoplastic Tendencies in the Human Skin. Wound Repair Regen (2020) 28(3):422–6. doi: 10.1111/wrr.12793
3. Xie J, Zhang X, Zhang K, Wu C, Yao G, Shi J, et al. Construction and Validation of the Diagnostic Model of Keloid Based on Weighted Gene Co-Expression Network Analysis (WGCNA) and Differential Expression Analysis. J Plast Surg Handb Surg (2022) 1–9. doi: 10.1080/2000656X.2021.2024557
4. Wang CH, Shan MJ, Liu H, Hao Y, Song KH, Wu WH, et al. Hyperbaric Oxygen Treatment on Keloid Tumor Immune Gene Expression. Chin Med J (Engl) (2021) 134(18):2205–13. doi: 10.1097/CM9.0000000000001780
5. Mrowietz U, Seifert O. Keloid Scarring: New Treatments Ahead. Actas Dermosifiliogr (2009) 100(Suppl 2):75–83. doi: 10.1016/s0001-7310(09)73382-4
6. Louw L. The Keloid Phenomenon: Progress Toward a Solution. Clin Anat (2007) 20(1):3–14. doi: 10.1002/ca.20374
7. Pai VB, Cummings I. Are There Any Good Treatments for Keloid Scarring After Sternotomy? Interact Cardiovasc Thorac Surg (2011) 13(4):415–8. doi: 10.1510/icvts.2010.264887
8. Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: The Paradigm of Skin Fibrosis - Pathomechanisms and Treatment. Matrix Biol (2016) 51:37–46. doi: 10.1016/j.matbio.2016.01.013
9. Xie J, Chen L, Cao Y, Wu D, Xiong W, Zhang K, et al. Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid. Front Immunol (2021) 12:783907. doi: 10.3389/fimmu.2021.783907
10. Xia Y, Wang Y, Xiao Y. Commentary: Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid. Front Immunol (2022) 13:868685. doi: 10.3389/fimmu.2022.868685
11. Dalkowski A, Schuppan D, Orfanos CE, Zouboulis CC. Increased Expression of Tenascin C by Keloids In Vivo and In Vitro. Br J Dermatol (1999) 141(1):50–6. doi: 10.1046/j.1365-2133.1999.02920.x
Keywords: keloid, immune microenvironment, inflammation, competitive endogenous RNA, bioinformatics
Citation: Xie J, Cao Y, Chen L and Wang M (2022) Response: Commentary: Single-Cell Sequencing Analysis and Weighted CoExpression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid. Front. Immunol. 13:923283. doi: 10.3389/fimmu.2022.923283
Received: 19 April 2022; Accepted: 02 June 2022;
Published: 28 June 2022.
Edited by:
Gerardo Guillen, Center for Genetic Engineering and Biotechnology (CIGB), CubaReviewed by:
Jorge Amador Berlanga-Acosta, Center for Genetic Engineering and Biotechnology (CIGB), CubaYssel Mendoza-Mari, Center for Genetic Engineering and Biotechnology (CIGB), Cuba
Copyright © 2022 Xie, Cao, Chen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ming Wang, wangming@jsph.org.cn